HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vicki G Davis Selected Research

Olanzapine (Zyprexa)

8/2009Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vicki G Davis Research Topics

Disease

8Schizophrenia (Dementia Praecox)
02/2015 - 04/2008
2Tardive Dyskinesia
03/2011 - 08/2009
1Inflammation (Inflammations)
12/2009
1Psychomotor Agitation (Akathisia)
08/2009
1Coronary Disease (Coronary Heart Disease)
10/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2008

Drug/Important Bio-Agent (IBA)

6Antipsychotic Agents (Antipsychotics)IBA
03/2011 - 04/2008
1N- (7- chloro- N- quinuclidin- 3- yl)benzo(b)thiophene- 2- carboxamideIBA
02/2015
1NicotineFDA Link
02/2015
1Aligeron (AS 2)IBA
03/2014
1C-Reactive ProteinIBA
12/2009
1Capsules (Microcapsules)IBA
08/2009
1Olanzapine (Zyprexa)FDA Link
08/2009
1ziprasidone (Geodon)FDA Link
08/2009
1Triglycerides (Triacylglycerol)IBA
08/2008